Iron-storing proteins and Cp were shown at higher levels in AD patients than in healthy people, based on Ashraf et al. However, it has been shown that AD sufferers express DMT1 and FPN1 at reduced levels (Ashraf et al., 2020). This evidence concerns the gene SLC40A1 and Alzheimer disease.